[Treatment success using topical drugs containing urea in papillomatosis cutis verrucosa (lymphostatic edema papillomatosis)].
Due to keratolytic and epidermis-thinning effects 10% urea/w/o is effective in the treatment of papillomatosis cutis verrucosa (lymphostatic papillomatosis). If possible, compression bandages should be used. Indirect lymphography reveals abnormalities of dermal lymphdrainage in papillomatosis cutis verrucosa.
Lindemayr
H
H
II. Universitäts-Hautklinik Wien.
D000287:Administration, Topical; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000008:administration & dosage*; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage*; D007642:Keratosis / Q000188:drug therapy*; D008209:Lymphedema / Q000150:complications*; D014508:Urea / Q000008:administration & dosage*; D014689:Venous Insufficiency / Q000150:complications
D003879:Dermatologic Agents; D007641:Keratolytic Agents; D014508:Urea
Therapieerfolge mit harnstoffhaltigen Externa bei Papillomatosis cutis verrucosa (Lymphostatischer Stauungspapillomatose).